<![CDATA[Merck and Daiichi pulled their bid for accelerated approval of I-DXd in small-cell lung cancer after FDA feedback.]]>Merck and Daiichi pulled their bid for accelerated approval of I-DXd in small-cell lung cancer after FDA feedback. What patients should ask now.

https://www.medicaldaily.com/merck-daiichi-ifinatamab-deruxtecan-sclc-application-withdrawn-479280?utm_source=flipboard&utm_medium=activitypub

Posted into FLIPBOARD EXCHANGE FEED 🗞️ @flipboard-exchange-feed-Econopass

]]>https://postcall.pub/topic/99a2aa0a-3031-4cae-8280-96a5a51f5ad7/merck-and-daiichi-pulled-their-bid-for-accelerated-approval-of-i-dxd-in-small-cell-lung-cancer-after-fda-feedback.RSS for NodeThu, 08 Oct 2026 23:23:44 GMTWed, 30 Sep 2026 08:50:41 GMT60